Clinical Trial Update: Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Ramadan fasting in patients with corticotrope deficiency treated with hydrocortisone or prednisolone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticotropin Deficiency
• Fasting

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)
• Prednisolone (Prednisolone)

Snippet

Sponsor: University Tunis El Manar | Conditions: Corticotropin Deficiency, Fasting | Phase 4 | Status: COMPLETED